|
The Chalk River, Ontario-based National Research Universal (NRU) reactor restart has been delayed until the second half of May 2010.
The Atomic Energy of Canada Limited (AECL) said 43 percent of the repair activities of the Chalk River, Ontario-based National Research Universal (NRU) reactor has been completed and that the reactor is expected to return to service by the end of April.
Covidien and the Institute of Atomic Energy in Poland have agreed to augment the global supply of molybdenum-99 (Mo-99) by adding the Poland’s Maria Research Reactor to the company's supply chain.
Nuclear Research and Consultancy Group of the Netherlands has extended the preparatory phase of the new research reactor Pallas, and the final choice for the vendor will be made by the end of 2010.
The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) has selected GE Hitachi Nuclear Energy to create a reliable U.S. supply of molybdenum-99 (Mo-99) without the use of highly enriched uranium (HEU) to overcome the isotope shortage.
The repair process of Chalk River, Ontario-based National Research Universal (NRU) reactor is progressing slowly and only 27 percent of the repair activities have been completed, delaying its reopening until April, according to Atomic Energy of Canada Limited (AECL).
The federal government of Canada has invited investors to submit proposals for Atomic Energy of Canada Limited’s (AECL) commercial Candu reactor division, as the next step in restructuring the Crown Corporation.
The Nuclear Research and Consultancy Group (NRG) submitted a request for the environmental impact assessment report for the PALLAS reactor that will replace the High Flux Reactor to the Dutch ministry of housing, spatial planning and the environment.
Lawson Health Research Institute will receive more than $1 million of the $5.4 million from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada to support research into medical isotope alternatives.
The American Medical Isotopes Production Act (HR 3276) was approved by the U.S. House of Representatives’ Energy and Commerce Committee on Oct. 21. The new legislation will help to fund projects for producing the medical isotope molybdenum-99 within the U.S., in order to ensure a consistent supply for American patients.
|
International Isotopes has raised approximately $3 million by a convertible debt securities purchase agreement to support continued engineering design and licensing of the company’s planned uranium processing and fluorine extraction facility.
The High Flux Reactor in Petten, the Netherlands is expected to restart in the second half of August, as the first activities to repair the reactor’s cooling water pipework started today, according to the Nuclear Research and Consultancy Group of the Netherlands.
Best Theratronics is manufacturing cyclotrons for the production of diagnostic and therapeutic medical isotopes to address the global medical isotope shortage.
Babcock & Wilcox Technical Services Group (B&W TSG) has been awarded $9 million from the National Nuclear Security Administration for the development of reactor technology for medical isotope production using low enriched uranium.
There will be no Covidien generator production from March 21-25 in the Americas and from March 20-23 in Europe, the Middle East and Africa due to lack of molybdenum-99 supply, as all five major medical isotope reactors in Europe, Canada and South Africa will be off-line during this period.
Rb-82 PET is gaining momentum in cardiac imaging with the technetium shortage continuing and an increase in reimbursements in the Hospital Outpatient Prospective Payment System for PET myocardial perfusion imaging by the Centers for Medicaid & Medicare Services (CMS).
The repair of the primary cooling water pipework of the High Flux Reactor in Petten, the Netherlands, is currently scheduled to commence on Feb. 19 2010, and the restart is scheduled in the second half of August 2010, according to the Nuclear Research and Consultancy Group (NRG) of the Netherlands.
Welder training and weld equipment testing and verification in the Chalk River, Ontario-based National Research Universal (NRU) reactor mock-up has been completed, according to the Atomic Energy of Canada Limited (AECL).
The U.S. House of Representatives has passed HR 3276—the American Medical Isotopes Production Act of 2009—by a roll call vote of 400-17. The legislation will help to fund projects for producing the medical isotope molybdenum-99 within the United States.
The Nuclear Research and Consultancy Group, which operates the High Flux Reactor in Petten, Netherlands, has plans to build a new reactor to produce medical isotopes.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.